MYCOBACTERIUM - ANVISA Registration 10322250071
Access comprehensive regulatory information for MYCOBACTERIUM in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10322250071 and manufactured by manufacturer not specified. The registration is held by QIAGEN BIOTECNOLOGIA BRASIL LTDA. with validity until Sep 05, 2026.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including HAIN LIFESCIENCE GMBH, BECTON DICKINSON AND COMPANY (SPARKS), and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamRelated Devices (2)
Registration Details
10322250071
25351662450201591
01334250000120
Company Information
Dates and Status
Sep 05, 2016
05/09/2026
09/18/2025 19:00:01
MYCOBACTERIUM
T-SPOT® TB
OXFORD IMMUNOTEC LTD
10338930301
Dec 18, 2023
MYCOBACTERIUM
T-SPOT® TB
Not specified
10338930301
Dec 18, 2023
MYCOBACTERIUM
AFIAS IGRA-TB
BODITECH MED INC.
10350840460
Jul 22, 2024
MYCOBACTERIUM
AFIAS IGRA-TB
Not specified
10350840460
Jul 22, 2024
MYCOBACTERIUM
STANDARD E TB-Feron ELISA
SD BIOSENSOR,INC.
80954880185
Jul 04, 2022
MYCOBACTERIUM
RIDA® TB Tubes
R-BIOPHARM AG
82890930018
Sep 15, 2025
MYCOBACTERIUM
RIDA® TB Tubes
Not specified
82890930018
Sep 15, 2025
MYCOBACTERIUM
RIDA®QUICK TB
Not specified
82890930015
Jul 07, 2025
MYCOBACTERIUM
RIDA®QUICK TB
R-BIOPHARM AG
82890930015
Jul 07, 2025
MYCOBACTERIUM
RIDASCREEN® TB
R-BIOPHARM AG
82890930012
Jun 23, 2025